DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia... Read more.
Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter
Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed... Read more.
Dubai Brings Together Sport Stars and Legends, Leaders and Decision-Makers on the Largest Global Platform to Shape the Future of Sports: the World Sports Summit
Under the directives of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum and the supervision of the Dubai Sports Council – The Summit, under the... Read more.
Prudential Financial Announces Leadership Alignment
NEWARK, N.J.–(BUSINESS WIRE)–Prudential Financial, Inc. (NYSE: PRU) today announced a realignment of its senior business leadership structure to streamline... Read more.
AppGate Introduces Agentic AI Core Protection
New Capability Secures Machine-driven Workloads at Scale, Extending Zero Trust Protection and Improving Compliance NEW YORK–(BUSINESS WIRE)–AppGate,... Read more.
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #animalhealth—Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference... Read more.
Ethos Capital Completes Continuation Vehicle for Identity Digital
New investment partners join to support company’s next phase of growth BOSTON–(BUSINESS WIRE)–Ethos Capital LP (Ethos) announced today that it has... Read more.
EMCOR Group, Inc. Announces Dividend Increase and Increase in Share Repurchase Authorization
NORWALK, Conn.–(BUSINESS WIRE)–EMCOR Group, Inc. (NYSE: EME) today announced that its Board of Directors (the “Board”) has approved an increase to... Read more.
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President,... Read more.
New Findings From athenahealth Reveal AI Use Advancing Beyond Administrative Tasks to Clinical Decision-Making Support
Research shows as clinician trust in AI grows, use cases are becoming more strategic, with leading adopters now using it to anticipate patient needs, close gaps... Read more.